Avtar S Dhillon's Net Worth

$36.1 Million

Estimate Recalculated May 29, 2025 03:03PM EST

Who is Avtar S Dhillon?

Avtar S Dhillon has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include Arch Therapeutics, Inc., GENETRONICS BIOMEDICAL CORP, Nemus Bioscience, Inc., Stevia First Corp., and ONCOSEC MEDICAL Inc.

SEC CIK

Avtar S Dhillon's CIK is 0001260933

Past Insider Trading and Trends

2016 was Avtar S Dhillon's most active year for acquiring shares with 10 total transactions. Avtar S Dhillon's most active month to acquire stocks was the month of April. 2018 was Avtar S Dhillon's most active year for disposing of shares, totalling 14 transactions. Avtar S Dhillon's most active month to dispose stocks was the month of January. 2015 saw Avtar S Dhillon paying a total of $3,031,165.00 for 1,567,500 shares, this is the most they've acquired in one year. In 2018 Avtar S Dhillon cashed out on 170,244 shares for a total of $52,367.21, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arch Therapeutics, Inc. (ARTH) Snapshot price: $4.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Jul 19
Form 4
+2.65%
220K
—
—
8.52M
Jul 19
Form 4
+5.06%
400K
—
—
8.3M
Feb 3
Form 4
+10.29%
737K
—
—
7.9M
May 3
Form 4
—
0
—
—
0
Aug 18
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Mar 23
Form 4
+2.29%
160.37K
—
—
7.16M
Jun 25
Form 3
—
0
—
—
0
No matching records found

INOVIO PHARMACEUTICALS, INC. (INO) Snapshot price: $6.15

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+30.86%
25K
$2.00
$50,000.00
106K
Dec 6
Form 4
+10.46%
7.67K
—
—
81K
May 11 - May 12
Form 4
+15.79%
10K
—
—
73.33K
May 12 - May 13
Form 4
—
0
—
—
0
May 13
Form 4
+8.57%
5K
—
—
63.33K
May 8
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Aug 10
Form 4
+9.38%
20K
$0.72
$14,400.00
233.33K
Jul 6
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Dec 9
Form 4
+55.47%
75K
—
—
210.21K
Feb 1
Form 4
+124.57%
75K
—
—
135.21K
May 4
Form 4
-55.47%
-75.00K
—
—
60.21K
Mar 30
Form 4/A
+124.57%
75K
—
—
135.21K
Mar 8
Form 4
+124.57%
75K
—
—
135.21K
Mar 8
Form 4
—
0
—
—
0
Mar 8
Form 4
—
0
—
—
0
Jan 15
Form 4
+19.93%
10K
$2.52
$25,236.00
60.19K
Oct 14
Form 4
∞
2
$5,882.36
$11,764.71
2
Sep 14
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Nov 7
Form 4
—
0
—
—
0
Aug 8
No matching records found

Nemus Bioscience, Inc. (SKYE) Snapshot price: $5.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 10
Form 3
—
0
—
—
0
No matching records found

Vitality Biopharma, Inc. (MLCT) Snapshot price: $0.195

President,CEO,CFO,Sec and Tres

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+1,028.43%
925.59K
—
—
1.02M
Jul 15
Form 4
—
0
—
—
0
May 21 - Jul 15
Form 4
-83.65%
-26.35M
—
-$57,970.00
5.15M
Feb 3 - Feb 24
Form 3
—
0
—
—
0
No matching records found

ONCOSEC MEDICAL Inc (ONCSQ) Snapshot price: $0.111

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+25.23%
12.5K
$1.55
$19,375.00
62.05K
Apr 17
Form 4
—
0
—
—
0
Jan 2
Form 4
+77.07%
62.42K
$1.39
-$52,367.21
143.43K
Jun 15 - Jul 5
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Mar 29
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Mar 4
Form 4
∞
10K
$4.36
$43,590.00
10K
Oct 16
Form 4
—
0
—
—
0
Aug 20
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Apr 25
Form 4
∞
9.91M
—
$2,973.14
9.91M
Mar 1
Form 3
—
0
—
—
0
No matching records found